Living Beyond Breast Cancer
Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill our mission of providing trusted information and a community of support, we offer on-demand emotional, practical, and evidence-based content that is meaningful to those newly diagnosed, in treatment, post-treatment, and living with metastatic disease.
For over 30 years, Living Beyond Breast Cancer has imparted wisdom and connection via conferences, events, a peer-to-peer helpline, and more. Today, we remain committed to creating a culture of acceptance—where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope.
Learn more at LBBC.ORG.
Living Beyond Breast Cancer
Do you know what the most common adverse events are with the various TROP2-targeting ADCs? Through a strategic collaboration, Living Beyond Breast Cancer and Medscape/Medscape Oncology present Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs), a free, internet-based activity intended for nurses, oncology nurses, nurse practitioners (NPs), oncology NPs, pharmacists, oncology pharmacists, oncologists, and obstetrician/gynecologists. The goal of this activity is for learners to be better able to recognize and manage treatment-related adverse events (TRAEs) associated with ADCs, including novel TROP2-targeting agents. Learn more and participate: bit.ly/48kN5Qu
1 year ago | [YT] | 1
View 0 replies
Living Beyond Breast Cancer
Do you know what the most common adverse events are with the various TROP2-targeting ADCs? Through a strategic collaboration, Living Beyond Breast Cancer and @medscape/Medscape Oncology present Adverse Event Management of TROP2-Targeting Antibody-Drug Conjugates (ADCs), a free, internet-based activity intended for nurses, oncology nurses, nurse practitioners (NPs), oncology NPs, pharmacists, oncology pharmacists, oncologists, and obstetrician/gynecologists. The goal of this activity is for learners to be better able to recognize and manage treatment-related adverse events (TRAEs) associated with ADCs, including novel TROP2-targeting agents. Learn more and participate: bit.ly/48kN5Qu
1 year ago (edited) | [YT] | 0
View 0 replies
Living Beyond Breast Cancer
Tomorrow, LBBC will be hosting Ask the expert: Updates from the 2023 San Antonio Breast Cancer Symposium with Stephanie Graff, MD, FACP, here on our YouTube channel. Make sure you are SUBSCRIBED and the “Bell” icon is on in order to be notified when the live event begins!
1 year ago | [YT] | 4
View 0 replies
Living Beyond Breast Cancer
3 years ago | [YT] | 3
View 0 replies